Profluent Partners With BioMarin to Design Novel Medicines Using AI
XX min read
TL;DR
● Collaboration pairs Profluent's AI models with BioMarin's enzyme replacement therapy expertise to advance next-generation candidates for genetically defined conditions
Read the full press here release for more.
Oops! Something went wrong while submitting the form.
Share on Social
